Publications
Laird, N.M., Ware, JH. 1983. Random Effects Models for Longitudinal Studies. Biometrics 38,963-974.
Ware J.H. 1985. Linear Models for the Analysis of Longitudinal Studies. Am. Statist. 39,95-101.
Laird, N.M., C. Donnelly, and Ware, JH. 1992. Longitudinal Studies with Continuous Responses. Stat. Methods Med. Research 1, 225-247.
Wypij, D., M. Pugh, and Ware, JH. 1993. Modeling Pulmonary Function Growth with Regression Splines. Statist. Sin. 3, 329-350.
Ware, JH, Antman, E.M. Equivalence Trials. 1997. N. Engl. J. Med 337, 1159-1160.
Treatment of Lead-exposed Children (TLC) Trial Group. 2000. Safety and Efficacy of Succimer in Toddlers with Blood Lead Levels of 20-µg/dL. Pediatric Research 48:593-599.
Rogan, W.J., Dietrich, K.N., Ware, JH, Dockery, D.W., Salganik, M., Radcliffe, J., Jones, R.L., Ragan, N.B., Chisolm, J.J., and Rhoads, G.G. 2001. The Effect of Chelation Therapy with Succimer on Neuropsychological Development in Children Exposed to Lead. N.Engl.J.Med. 344, 1421-1426.
Bartels, S.J., Coakley, E.H., Zubritsky, C., Ware, JH, Miles, K.M., Arean, P.A., Chen, H, Oslin, D.W., Llorente, M.D., Costantino, G., Quijano, L., McIntyre, J.S., Linkins, K.W., Oxman, T.E., Maxwell, J., Levkoff, S.E. 2004. Improving Access to Geriatric Mental Health Services: A Randomized Trial Comparing Treatment Engagement in Integrated and Enhanced Referral Care for Depression, Anxiety, and At-risk Alcohol Use. Am. J. Psychiatry 161:8 1455-1462.
Deitrich, K.N., Ware, JH, Saklganik, M., Radcliffe, J., Rogan, W.J., Rhoads, G., Fay, M.E., Davoli, C.T., Denckla, M.B., Bornschein, R.L., Swarz, D., Dockery, D.W., Abubato, S., Jones, R.I. 2004. Effect of Chelation Therapy on the Neuropsychological and Behavioral Development of Lead-Exposed Children Following School Entry. Pediatrics 114:19-26.
Weuve, J., Kang, J.H., Manson, J.E., Breteler, M, Ware, JH, Grodstein, F. 2004. Physical Activity, Including Walking, and Cognitive Function in Older Women. JAMA. 292:1454-1461.
Ware, JH (Chair) and the IOM Committee. 2005. IOM Report of the Review of the HIVNET 012 Perinatal HIV Prevention Study. The National Academies Press, Washington, DC.
Stone, G, McLaurin, BT, Cox, DA, Bertrand, ME, Lincoff, AM, Moses, JW, White HD, Pocock, SJ, Ware, JH, Feit, F, Columbo, A, Aylward, PE, Cequier, AR, Darius, H, Desmet, W, Ebrahimi, R, Hamon, M, Rasmussen, LH, Rupprecht, HJ, Hoekstra, J, Mehran, R, and Ohman, EM (for the ACUITY Investigators). 2006. Bivalirudin for Patients with Acute Coronary Syndromes. N. Engl. J. Med. 355(21):2203-16.
Stone, G, Bertrand, ME, Moses, JW, Ohman EM, Lincoff, AM, Ware, JH, Pocock, SJ, McLaurin, BT, Cox, DA, Jafar, MZ, Chandna, H, Hartmann, F, Leisch, F, Strasser, RH, Desaga, M, Stuckey, TD, Zelman, RB, Lieber, IH, Cohen, DJ, Mehran, R, White, HD (and ACUITY Investigators). 2007. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: The ACUITY Timing Trial. J. Am. Med. Assoc. 297(6):591-602.
Stone, GW, White, HD, Ohman, EM, Bertrand, ME, Lincoff, AM, McLaurin, BT, Cox, DA, Pocock, SJ, Ware, JH, Feit, F, Colombo, A, Manoukian, SV, Lansky, AJ, Mehran, R, Moses, JW (for The ACUITY Trial investigators). 2007. Bivalirudin in Patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from The ACUITY Trial. The Lancet 369(9565):907-919.
Wang MS, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. 2007. Statistics in Medicine - Reporting of Subgroup Analyses in Clinical Trials. N Engl J Med 357:21.
Stone GW, Ware JH, Bertrand, ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ. 2007. Antithrombotic Strategies in Patients with Acute Coronary Syndromes Undergoing Early Invasive Management: One-Year Results from the ACUITY Trial. J Am Med Assoc 298:2497- 2506.
Gao P, Ware JH. 2008. Assessing non-inferiority: A combination approach. Statist in Med 27:392-406.
Gao P, Ware JH, Mehta C. 2008. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharmaceutical Statistics. In Press.
Krieger N, Chen JT, Ware JH, Kaddour A. 2008. Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes and Control. In Press.
Mehta C, Gao P, Ware JH, Bhatt, D, Harrington, R, Skerjanec, S. 2008. Statistical primer for Cardiovascular Research Stopping Rules and Adaptive Designs. Circulation Submitted.
Editorials:
Ware JH, Ed. Particulate Air Pollution and Mortality - Clearing the Air. N. Engl. J. Med. 343, 1798-1799, 2000.
Ware, JH, Rogan, W, Editorial. Exposure to Lead in Children-How Low is Low Enough? N. Engl. J. Med 348:16,1515-1516, 2003.
Ware, JH, Editorial. Interpreting Incomplete Data in Studies of Diet and Weight Loss. N. Engl. J. Med. 348:21, 2136, 2003.
Ware, JH, Perspective. The National Emphysema Treatment Trial - How Strong is the Evidence? N. Engl. J. Med. 348:21, 2055-2056, 2003.
Ware JH, Perspective: Statistics and Medicine: The Limitations of Risk Factors as Prognostic Tools. N. Engl. J. Med. 355:25, 2615-2617, 2006